110 related articles for article (PubMed ID: 8298142)
1. Hematopoietic repopulation of adult mice with beta-thalassemia.
Barker JE; Compton ST
Blood; 1994 Feb; 83(3):828-32. PubMed ID: 8298142
[TBL] [Abstract][Full Text] [Related]
2. Selective erythroid replacement in murine beta-thalassemia using fetal hematopoietic stem cells.
Bethel CA; Murugesh D; Harrison MR; Mohandas N; Rubin EM
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10120-4. PubMed ID: 7980734
[TBL] [Abstract][Full Text] [Related]
3. Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice.
Beauchemin H; Blouin MJ; Trudel M
J Biol Chem; 2004 May; 279(19):19471-80. PubMed ID: 15004025
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
de Franceschi L; Rouyer-Fessard P; Alper SL; Jouault H; Brugnara C; Beuzard Y
Blood; 1996 Feb; 87(3):1188-95. PubMed ID: 8562946
[TBL] [Abstract][Full Text] [Related]
5. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.
Persons DA; Allay ER; Sabatino DE; Kelly P; Bodine DM; Nienhuis AW
Blood; 2001 May; 97(10):3275-82. PubMed ID: 11342459
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
[TBL] [Abstract][Full Text] [Related]
7. Murine and math models for the level of stable mixed chimerism to cure beta-thalassemia by nonmyeloablative bone marrow transplantation.
Roberts C; Kean L; Archer D; Balkan C; Hsu LL
Ann N Y Acad Sci; 2005; 1054():423-8. PubMed ID: 16339691
[TBL] [Abstract][Full Text] [Related]
8. The hematopoietic stem cells of alpha-thalassemic mice.
Barker JE; McFarland E
Blood; 1985 Sep; 66(3):595-601. PubMed ID: 3896346
[TBL] [Abstract][Full Text] [Related]
9. Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen.
Bradley MB; Sattler RM; Raftopoulos H; Ward M; Grossman IR; Townes TM; Ryan TA; Bank A
Biol Blood Marrow Transplant; 2002; 8(8):453-61. PubMed ID: 12234171
[TBL] [Abstract][Full Text] [Related]
10. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.
Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta-thalassemia.
Villeval JL; Rouyer-Fessard P; Blumenfeld N; Henri A; Vainchenker W; Beuzard Y
Blood; 1994 Aug; 84(3):928-33. PubMed ID: 8043875
[TBL] [Abstract][Full Text] [Related]
12. Fetal hematopoietic stem cell transplantation into beta-thalassemic mice.
Bethel CA; Muragesh D; Harrison MR; Mohandas N; Rubin ER
J Pediatr Surg; 1993 Oct; 28(10):1232-7; discussion 1237-8. PubMed ID: 7903357
[TBL] [Abstract][Full Text] [Related]
13. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
Rivella S; May C; Chadburn A; Rivière I; Sadelain M
Blood; 2003 Apr; 101(8):2932-9. PubMed ID: 12480689
[TBL] [Abstract][Full Text] [Related]
14. Correction of murine beta-thalassemia by partial bone marrow chimerism: selective advantage of normal erythropoiesis.
van den Bos C; Kieboom D; Wagemaker G
Bone Marrow Transplant; 1993 Jul; 12(1):9-13. PubMed ID: 8374541
[TBL] [Abstract][Full Text] [Related]
15. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.
Bohl D; Bosch A; Cardona A; Salvetti A; Heard JM
Blood; 2000 May; 95(9):2793-8. PubMed ID: 10779423
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells.
Persons DA; Allay ER; Sawai N; Hargrove PW; Brent TP; Hanawa H; Nienhuis AW; Sorrentino BP
Blood; 2003 Jul; 102(2):506-13. PubMed ID: 12663444
[TBL] [Abstract][Full Text] [Related]
17. Defective assembly of membrane proteins in erythroid precursors of beta-thalassemic mice.
Yuan J; Rubin E; Aljurf M; Ma L; Schrier SL
Blood; 1994 Jul; 84(2):632-7. PubMed ID: 8025288
[TBL] [Abstract][Full Text] [Related]
18. Long-term correction of beta-thalassemia with minimal cellular requirement and transplantation modalities.
Felfly H; Trudel M
Mol Ther; 2007 Sep; 15(9):1701-9. PubMed ID: 17519891
[TBL] [Abstract][Full Text] [Related]
19. Abnormal assembly of membrane proteins in erythroid progenitors of patients with beta-thalassemia major.
Aljurf M; Ma L; Angelucci E; Lucarelli G; Snyder LM; Kiefer CR; Yuan J; Schrier SL
Blood; 1996 Mar; 87(5):2049-56. PubMed ID: 8634456
[TBL] [Abstract][Full Text] [Related]
20. Different repopulation profile between erythroid and nonerythroid progenitor cells in genetically anemic W/Wv mice after bone marrow transplantation.
Nakano T; Waki N; Asai H; Kitamura Y
Blood; 1989 Oct; 74(5):1552-6. PubMed ID: 2790184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
